Visiongain publishes Nasal Drug Delivery Technology Market Forecast 2020-2030 report

News provided by

Aug 24, 2020, 08:00 ET

LONDON, Aug. 24, 2020 /PRNewswire/ -- Nasal Sprays: Non-Pressurised Containers & Pressurised Containers, Nasal Drops & Liquids, Nasal Gels, Nasal Powders; Multi Dose Nasal Devices, Bi-Dose Nasal Devices, Unit Dose Nasal Devices; Allergic and Non-Allergic Rhinitis, Nasal Congestion, Asthma; Ambulatory Surgery Centres, Hospitals, Specialty Clinics, Vaccination Centres

The Global Nasal Drug Delivery Technology Market is estimated at $44,385 m in 2019 and is expected to grow at a CAGR of 7.8% from 2020-2025. In 2019, the Global Nasal Drug Delivery Technology Market was dominated by the nasal sprays submarket which held 33.2% of the overall market.

How this report will benefit you

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 185-page report you will receive 54 charts– all unavailable elsewhere.

The 185-page Visiongain report provides clear detailed insight into the Global Nasal Drug Delivery Technology Market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

To request sample pages from this report please email [email protected] or refer to our website: https://www.visiongain.com/report/nasal-drug-delivery-technology-report-2020-2030/#download_sampe_div

Report Scope

• Revenue and growth forecasts from 2020 to 2030 for the Global Nasal Drug Delivery Technology market.

• Revenue and growth forecasts from 2020 to 2030 for the Global Nasal Drug Delivery Technology Market by the dosage form:

– Dosage Form: Nasal Sprays, Nasal Drops & Liquids, Nasal Gels, Nasal Powders

– Nasal Sprays: Non-pressurized Containers and Pressurized Containers

• Revenue and growth forecasts from 2020 to 2030 for the Global Nasal Drug Delivery Technology Market by System:

– Nasal Unidose Devices

– Nasal Bi Dose Devices

– Nasal Multi Dose Devices

• Revenue and growth forecasts from 2020 to 2030 for the Global Nasal Drug Delivery Technology Market by Application:

– Asthma

– Allergic and Non-Allergic Rhinitis

– Nasal Congestion

• Revenue and growth forecasts from 2020 to 2030 for the Global Nasal Drug Delivery Technology Market by End User:

– Hospitals

– Ambulatory Surgery Center

– Specialty Clinics

– Vaccination Centers

• Revenue and growth forecasts from 2020 to 2030 for the leading national markets:

– United States

– Canada

– Brazil

– Mexico

– Rest of Latin America

– Germany

– UK

– Italy

– France

– Spain

– Nordic

– Benelux

– Rest of Western Europe

– Russia

– Poland

– Rest of Eastern Europe

– Japan

– China

– India

– Australia & New Zealand

– ASEAN

– Rest of Asia-Pacific

– GCC Countries

– South Africa

– North Africa

– Rest of MEA

• This report profiles the leading companies that market nasal drug delivery devices:

– 3M Company

– Becton, Dickinson and Company

– GlaxoSmithKline plc

– Johnson & Johnson

– Merck & Co., Inc.

– Pfizer Inc.

– Teleflex Incorporated

– Naveh Pharma Ltd.

– OptiNose US, Inc.

– Pendopharm

– AptarGroup, Inc.

• This report provides qualitative analysis of the Global Nasal Drug Delivery Technology market. This report discusses the Porter's Five Forces Analysis, as well as the Drivers and Challenges of this market.

Visiongain's study is intended for anyone requiring commercial analyses for the Global Digital Wound Care Management market. You find data, trends and predictions.

To request a report overview of this report please email [email protected] or refer to our website: https://www.visiongain.com/report/nasal-drug-delivery-technology-report-2020-2030/

Did you know that we also offer a report add-on service? Email [email protected] to discuss any customized research needs you may have.

Companies covered in the report include:

3M Company

Allergy, Asthma and Clinical Immunology

American Academy of Allergy Asthma and Immunology

American Hospital of Paris

American Thoracic Society

AptarGroup, Inc.

Asthma and Allergy Foundation of America

AstraZeneca

Becton, Dickinson and Company